Integrated Biopharma, Inc.
INBP
$0.32
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.73M | 3.62M | 2.96M | 2.46M | 2.27M |
| Total Receivables | 3.98M | 5.43M | 5.08M | 4.23M | 4.39M |
| Inventory | 10.47M | 9.36M | 10.08M | 11.07M | 11.22M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 440.00K | 356.00K | 428.00K | 398.00K | 432.00K |
| Total Current Assets | 19.62M | 18.76M | 18.55M | 18.15M | 18.31M |
|
|
|||||
| Total Current Assets | 19.62M | 18.76M | 18.55M | 18.15M | 18.31M |
| Net Property, Plant & Equipment | 2.60M | 2.75M | 2.95M | 3.09M | 3.41M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.32M | 3.39M | 4.16M | 4.41M | 4.46M |
| Total Assets | 25.54M | 24.90M | 25.66M | 25.66M | 26.18M |
|
|
|||||
| Total Accounts Payable | 2.80M | 2.27M | 2.50M | 2.81M | 2.76M |
| Total Accrued Expenses | 1.49M | 1.30M | 1.64M | 1.80M | 2.31M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 474.00K | 679.00K | 844.00K | 964.00K | 954.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.76M | 4.25M | 4.98M | 5.58M | 6.03M |
|
|
|||||
| Total Current Liabilities | 4.76M | 4.25M | 4.98M | 5.58M | 6.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 287.00K | 336.00K | 292.00K | 359.00K | 604.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.05M | 4.58M | 5.27M | 5.93M | 6.63M |
|
|
|||||
| Common Stock & APIC | 51.88M | 51.84M | 51.72M | 51.68M | 51.62M |
| Retained Earnings | -31.30M | -31.42M | -31.24M | -31.85M | -31.97M |
| Treasury Stock & Other | -99.00K | -99.00K | -99.00K | -99.00K | -99.00K |
| Total Common Equity | 20.49M | 20.32M | 20.38M | 19.73M | 19.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.49M | 20.32M | 20.38M | 19.73M | 19.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.49M | 20.32M | 20.38M | 19.73M | 19.55M |
|
|
|||||